Skip to main content

Change location

You are currently on the Poland (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
    • Poland (English)
  • Home
  • we are bracco
    We are Bracco

    Welcome to a World of contrasts

    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
  • Our Portfolio

    Proven offerings for a proven difference

    • X-ray/CT
      • Contrast agents

        • Iomeron
      • Medical devices

        • CT Exprès
        • Empower CTA+
    • MRI
      • Contrast agents

        • MultiHance
        • ProHance
      • Medical Devices

        • Empower MR
    • Ultrasound
      • Contrast agents

        • Sonovue
    • Nuclear medicine
    • Interventional cardiology
      • Contrast agents

        • Iomeron
      • Medical devices

        • ACIST CVi
        • ACIST HDi
        • ACIST RXi
    • Digital solutions
    • Oncology
    • Cardiology
  • Woman looking into microscope
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
  • knowledge
    Knowledge

    Current activities and future opportunities

    • E-learning
    • Partnerships in education
    • Events
  • Bracco sustainability report 2024
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
Page
Cardiology Despite the availability of effective therapies, ischaemic heart disease remains the leading cause of death around the world. Early and proper diagnosis is key to reducing cardiovascular mortality and diagnostic imaging plays a crucial role here.
A surgeon preparing for surgery.
Page
Oncology According to the World Health Organization (WHO), in 2020 cancer accounted for nearly 10 million deaths worldwide – that’s almost one in every six deaths – with cancers of the lung, colon, and rectum, and prostate being the most common.
Laboratory researcher is looking through a microscope.
Article
Talking Images podcast: The sustainable way – voices of action Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?
sustainability podcast
Product
ProHance ProHance® is a macrocyclic, non-ionic gadolinium-based contrast agent, characterized by very low osmolality and viscosity.
Bracco logo
Product
CT Exprès CT Exprès™ Contrast Media Delivery System is the result of several years of development targeted at better satisfying customer's needs, cost containment considerations and safety concerns.
Bracco logo
Product
Iomeron Iomeron® is a non-ionic, monomeric, iodine contrast agent for radiology
Bracco logo
Product
Empower CTA+ The Empower CTA+ Injector System is the robust and intuitive syringe-based injector for CT imaging by Bracco, re-engineered in order to ensure operational efficiencies and patient safety.
Bracco logo
Product
MultiHance MultiHance® (gadobenate dimeglumine) is a gadolinium-based contrast agent (GBCA) currently approved in the European Union, Norway and Iceland for use in diagnostic magnetic resonance imaging (MRI) of the liver in adult and in pediatric patients older than two years of age.
Bracco logo
Product
Empower MR World's first hydraulic-powered MR injector eliminates batteries and associated issues.
Bracco logo
Product
Sonovue As the result of many years of research and development SonoVue® is a second-generation ultrasound contrast agent, designed and optimized for pressure resistance.
Bracco logo
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182